Key result
Blood coagulation operates as a dynamic molecular machine driving thrombosis, inflammation, and innate immunity.
Answers are grounded in this paper and cite their sources.
The human blood coagulation system comprises a series of linked glycoproteins that upon activation induce the generation of downstream enzymes ultimately forming fibrin. This process is primarily important to arrest bleeding (hemostasis). Hemostasis is a typical example of a molecular machine, where the assembly of substrates, enzymes, protein cofactors and calcium ions on a phospholipid surface markedly accelerates the rate of coagulation. Excess, pathological, coagulation activity occurs in "thrombosis", the formation of an intravascular clot, which in the most dramatic form precipitates in the microvasculature as disseminated intravascular coagulation. Thrombosis occurs according to a biochemical machine model in the case of atherothrombosis on a ruptured atherosclerotic plaque, but may develop at a slower rate in venous thrombosis, illustrating that the coagulation machinery can act at different velocities. The separate coagulation enzymes are also important in other biological processes, including inflammation for which the rapid conversion of one coagulation factor by the other is not a prerequisite. The latter role of coagulation enzymes may be related to the old and probably maintained function of the coagulation machine in innate immunity.
No takes yet. Share an insight, caveat, or question.
Spronk et al. (2003) conducted a review in Thrombosis and hemostasis. The blood coagulation system functions as a molecular machine at varying velocities in hemostasis and thrombosis, while its enzymes also mediate inflammation and innate immunity.
Synapse has enriched 10 related papers. Consider them for comparative context: